Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eterna Therapeutics Inc.

1.56
-0.1700-9.83%
Post-market: 1.620.0600+3.85%19:23 EDT
Volume:54.69K
Turnover:87.82K
Market Cap:11.48M
PE:-0.03
High:1.70
Open:1.70
Low:1.53
Close:1.73
Loading ...

Ernexa Therapeutics Regains Nasdaq Compliance Over Minimum Bid Price Rule

MT Newswires Live
·
09 Jul

Ernexa Therapeutics regains compliance with Nasdaq listing rules

TIPRANKS
·
09 Jul

Ernexa Therapeutics Inc. Replaces Grant Thornton Amid Internal Control Weakness_issue

Reuters
·
08 Jul

BRIEF-Ernexa Therapeutics Expands Advisory Board As It Prepares For Clinical Development

Reuters
·
25 Jun

Ernexa secures $6M in second closing under securities purchase agreement

TIPRANKS
·
24 Jun

Press Release: Ernexa Therapeutics Secures $6 Million in Second Closing Under Securities Purchase Agreement

Dow Jones
·
24 Jun

Ernexa Therapeutics Shares Fall Pre-Bell Following Reverse Stock Split

MT Newswires Live
·
13 Jun

Charles Cherington, 10% Owner, Reports Acquisition of Common Shares in Ernexa Therapeutics Inc

Reuters
·
12 Jun

Eterna Therapeutics Files for Resale of 57 Million Shares

MT Newswires Live
·
12 Jun

Ernexa Therapeutics files to sell 57.05M shares of common stock for holders

TIPRANKS
·
12 Jun

Ernexa Therapeutics announces 1-for-15 reverse stock split

TIPRANKS
·
10 Jun

Ernexa Therapeutics Inc. Completes Second Closing of Private Placement, Issuing 57.65 Million Shares and Raising $7 Million

Reuters
·
10 Jun

Ernexa Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
03 Jun

Ernexa Therapeutics Presented Promising Data on Innovative Cell Therapy Treatment at AACR Annual Meeting 2025

GlobeNewswire
·
29 Apr

Ernexa Therapeutics Announces New Data to be Presented at AACR Annual Meeting 2025

GlobeNewswire
·
22 Apr

Ernexa Therapeutics Closes New Funding Round

GlobeNewswire
·
03 Apr